Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults

Chest

Volumn 100, Issue 4, 1991, Pages 977-984

  Gorse, G J ^a   Belshe, R B ^a   Munn, N J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERTENSION; IMMUNOGENICITY; INFLUENZA VIRUS A; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0025944316     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.100.4.977     Document Type: Article

References (22)

1. Williams WW Hickson MA Kane MA Kendal AP Spika JS Hinman AR. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med 108 1988 616 625
2. Centers for Disease Control. Influenza vaccination levels in selected states—behavioral risk factor surveillance system, 1987. MMWR 1989; 38:124-33
3. Gorse GJ Belshe RB Munn NJ. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases. J Clin Microbiol 24 1986 336 342
4. Gorse GJ Belshe RB Munn NJ. Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines. J Clin Microbiol 26 1988 911 918
5. Cox NJ Maassab HF Kendal AP. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25° between recent H3N2 and H1N1 epidemic strains and cold-adapted A/Ann Arbor/6/60. Virology 97 1979 190 194
6. American College of Chest Physicians. Report of the Section on Respiratory Pathophysiology: statement on spirometry. Chest 1983; 83:547-50
7. Gardner RM. Standardization of spirometry: a summary of recommendations from the American Thoracic Society: the 1987 update. Ann Intern Med 108 1988 217 220
8. Belshe RB Van Voris LP Mufson MA. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J Infect Dis 145 1982 311 319
9. World Health Organization. The hemagglutination inhibition test for influenza viruses. Atlanta: Centers for Disease Control; 1975.
10. Phelan MA Mayner RE Bucher DJ Ennis FA. Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. J Biol Stand 8 1980 233 242
11. Murphy BR Phelan MA Nelson DL Yarchoan R Tierney EL Alling DW Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol 13 1981 554 560
12. Murphy BR Nelson DL Wright PF Tierney EL Phelan MA Chanock RM. Secretory and systemic immunological response in children infected with live-attenuated influenza A virus vaccines. Infect Immun 36 1982 1102 1108
13. Smith CB Kanner RE Golden CA Klauber MR Renzetti AD Jr. Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases. J Infect Dis 141 1980 271 280
14. Powers DC Sears SD Murphy BR Thumar B Clements ML. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines. J Clin Microbiol 27 1989 2666 2671
15. MRC Advisory Group on Pulmonary Function Tests in Relation to Live Influenza Vaccines. Trials of live attenuated influenza virus vaccine in patients with chronic obstructive airways diseases. Br J Dis Chest 1984; 78:236-47
16. Brandriss MW Betts RF Mathur U Douglas RG Jr. Responses of elderly subjects to monovalent A/USSR/77 (H1N1) and trivalent A/USSR/77 (H1N1) - A/Texas/77 (H3N2) - B/Hong Kong/72 vaccines. Am Rev Respir Dis 124 1981 681 684
17. Brandriss MW Schlesinger JJ Douglas RG Jr. Responses of elderly subjects to a new subunit influenza virus vaccine. J Infect Dis 145 1982 277
18. Clements ML Betts RF Murphy BR. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection. Lancet 1 1984 705 708
19. Clements ML Murphy BR. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol 23 1986 66 72
20. Johnson PR Feldman S Thompson JM Mahoney JD Wright PF. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis 154 1986 121 127
21. Zahradnik JM Kasel JA Martin RR Six HR Cate TR. Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine. J Med Virol 11 1983 277 285
22. Treanor JJ Roth FK Betts RF. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults. J Clin Microbiol 28 1990 596 599